Skip to content
Trial Eligibility
Menu

Stimulant Effects on Disruptive Behavior

NCT03420339

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this study is to determine the effects of stimulant medication on disruptive behavior, function, preference and choice; however, it is primarily methodological and will add to current research by establishing an effective evaluation of the impact of stimulant medication on these behaviors.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Attention Deficit Hyperactivity Disorder
  • Problem Behavior

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
48 months to 12 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Matthew J O'Brien, PhD, BCBA-D
Last updated on ClinicalTrials.gov
March 17, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Iowa · 1

  • University of Iowa Hospitals and Clinics · Iowa City, IA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.